Alastair Thompson, BSc (Hons), MBChB, MD, FRCS (Ed)

Professor and Chief, Section of Breast Surgery
Baylor College of Medicine

Alastair Thompson, BSc (Hons), MBChB, MD, FRCS (Ed) Photo

Positions

Professor and Chief, Section of Breast Surgery
Division of Surgical Oncology
Baylor College of Medicine

Co-Director, Lester and Sue Smith Breast Center
Dan L Duncan Comprehensive Cancer Center

Olga Keith Wiess Chair of Surgery
Baylor College of Medicine

Co-Associate Director for Clinical research
Dan L Duncan Comprehensive Cancer Center

Addresses

Baylor Medicine at McNair Campus (Clinic)
Lester and Sue Smith Breast Center
Dan L Duncan Comprehensive Cancer Center
7200 Cambridge St, 7th floor
Houston, Texas 77030
United States
(713) 798-2262
Google Maps
Baylor Medicine at McNair Campus (Hospital)
Lester and Sue Smith Breast Center
Dan L Duncan Comprehensive Cancer Center
7200 Cambridge St, 7th floor
Houston, Texas 77030
United States
(713) 798-2262
Google Maps
Baylor Medicine at McNair Campus (Office)
Lester and Sue Smith Breast Center
Dan L Duncan Comprehensive Cancer Center
7200 Cambridge St, 7th floor
Houston, Texas 77030
United States
(713) 798-2262
Google Maps
Baylor Medicine at McNair Campus (Work)
Lester and Sue Smith Breast Center
Dan L Duncan Comprehensive Cancer Center
7200 Cambridge St, 7th floor
Houston, Texas 77030
United States
(713) 798-2262
Google Maps

Education

  • Residency at Royal Infirmary of Edinburgh
    Edinburgh

    General Surgery

  • Research Fellowship at Imperial Cancer Research Fund
    Edinburgh
  • MD from University of Edinburgh
    Edinburgh

    Molecular Biology

  • MBChB from University of Edinburgh
    Edinburgh

    Medicine Surgery

  • BSc from University of Edinburgh
    Edinburgh

    Medical Science Anatomy

Gender

  • Male

Professional Statement

Over the last 35 years, Professor Thompson has trained and practiced as a clinician-scientist focused on multidisciplinary patient care alongside translational “bench to bedside” studies and innovative clinical trials in cancer. He initiated and lead a successful breast cancer laboratory program, provided leadership for a cancer center in the United Kingdom (UK), chaired the UK national breast cancer trials portfolio of 120 studies and engaged in a range of pivotal roles in key drug, radiation therapy and surgical trials involving the UK, Europe, the United States and Australia. Since moving to the US in 2014, he has specialized in improving treatment for breast cancer patients with innovative localization techniques for breast conservation and axillary node surgery and to minimize patient impact through to skin sparing and nipple sparing mastectomy with autologous reconstruction where required. Unusually for a surgeon, Professor Thompson has preclinical and practical experience in the design, implementation, monitoring and reporting of early through to late phase drug and medical device trials. Recent pharmaceutical experience includes active leadership of international trials such as the SOLE, MA32, MINDACT, and KRISTINE trials; He currently chairs several phase II and phase III data monitoring committees and trials steering groups. For radiotherapy, he co-authored the ASTRO ABPI consensus guidelines and has contributed to intraoperative and hypofractionation trials. Since transitioning to the US, national leadership roles include co-chairing the Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for low risk DCIS, co-chairing the NCI-BCSC proposed “no surgery” clinical trial planning committee and membership of the NCI BOLD taskforce and leadership positions within TBCRC (Loco-regional Subgroup co-Chair) and SWOG (Translational Medicine Breast Group Chair). Professor Thompson is an active member of ASCO, SSO, ASBrS and AACR. With successful peer reviewed funding from US government and international charitable sources linking laboratory to clinical studies, successful supervision of 24 postgraduate students and some 350 peer reviewed publications in the highest impact factor clinical and scientific journals, improved care of those with cancer is his key mission.

Professional Achievements

  • James IV Association of Surgeons Travelling Fellowship
    James IV Association

  • King James IV Professorship in Surgery
    Royal College of Surgeons of Edinburgh

  • Lister Prize for Surgery
    University of Edinburgh

  • William Leslie Prize for Surgery
    University of Edinburgh

  • Director's Service Award
    National Cancer Institute

  • 2017 Top Performer

Professional Interests

  • Ductal Carcinoma In Situ (DCIS)

  • Nipple and Skin Sparing Mastectomy

  • Breast Conservation Surgery

  • Breast Surgery

  • Surgical Oncology

  • Sentinel Lymph Node Biopsy

  • Mastectomy

  • Translational research

  • Clinical trials

  • Patient outcomes

Professional Specialties

  • Ductal Carcinoma In Situ (DCIS)

  • Nipple and Skin Sparing Mastectomy

  • Breast Conservation Surgery

  • Breast Surgery

  • Mastectomy

  • Breast Cancer